Non-melanoma skin cancer is the most common form of skin cancer among the Caucasians. Management of non-melanoma skin cancers involves various therapies viz. surgical excision, radiotherapy, cryosurgery, curettage, and cautery. Mohs micrographic surgery (MMS) is the widely accepted gold standard treatment for aggressive, clinically progressed skin cancers.
It offers around 95%-99% cure rates within five years of treatment in patients with basal cell carcinoma and squamous cell carcinoma. The main advantage of MMS over other therapies is precise microscopic control over the entire tumor margin as well as a high rate of conservation of healthy skin tissues. According to Mohs Appropriate Use Criteria (AUC), which of the following conditions would be non-suitable for performing Mohs micrographic surgery? Option A: 2 cm recurrent superficial basal cell carcinoma on the arm Option B: 1 cm…
